Blocking LAIR1 signaling in immune cells inhibits tumor development
The current immune checkpoint blockade therapy has been successful in treating some cancers but not others. New molecular targets and therapeutic approaches of cancer immunology need to be identified. Leukocyte associated immunoglobulin like receptor 1 (LAIR1) is an immune inhibitory receptor expres...
Main Authors: | Jingjing Xie, Xun Gui, Mi Deng, Heyu Chen, Yuanzhi Chen, Xiaoye Liu, Zhiqiang Ku, Lingxiao Tan, Ryan Huang, Yubo He, Bruce Zhang, Cheryl Lewis, Kenian Chen, Lin Xu, Jian Xu, Tao Huang, X. Charlene Liao, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.996026/full |
Similar Items
-
Single-cell RNA sequencing highlights the role of distinct natural killer subsets in sporadic amyotrophic lateral sclerosis
by: Esther Álvarez-Sánchez, et al.
Published: (2025-01-01) -
Chimeric antigen receptor‐engineered adoptive cell therapy for AML: Current status and future perspectives
by: Yue Huang, et al.
Published: (2022-06-01) -
Finding potential targets in cell-based immunotherapy for handling the challenges of acute myeloid leukemia
by: Amir Hossein Kheirkhah, et al.
Published: (2024-09-01) -
Dissociation and inDrops microfluidic encapsulation of human gut tissues for single-cell atlasing studies
by: Alan J. Simmons, et al.
Published: (2022-09-01) -
Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies
by: Diana C. Lopez, et al.
Published: (2022-10-01)